Clicky

  • Login
  • Register
  • Submit Your Content
  • Contact Us
Friday, June 13, 2025
World Tribune
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
Submit
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
No Result
View All Result
World Tribune
No Result
View All Result

Brooklyn Health scores $6.5M to improve mental health assessment in clinical trials

May 27, 2025
in Health
Reading Time: 4 mins read
A A
Brooklyn Health scores .5M to improve mental health assessment in clinical trials
0
SHARES
ShareShareShareShareShare

Brooklyn Health scores $6.5M to improve mental health assessment in clinical trials

Brooklyn Health, a neuroscience technology company, secured $6.5 million in seed funding. 

The round was led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio and Blue Falcon Capital.

WHAT IT DOES

Brooklyn Health measures mental health outcomes in clinical trial participants.

According to Brooklyn Health, central nervous system clinical trials depend heavily on clinical interviews as their primary outcome measure for treatment. The company says the interviews enable the scoring of symptoms via observation and are essential to measure variations in response to treatment.

In a statement, the company said that “clinical interviews are difficult to standardize and scoring is subjective and susceptible to biases,” and could result in undependable outcome measures and is also linked to the placebo response, which may contribute to the high failure rate of CNS clinical trials.

Brooklyn Health said those obstacles might be alleviated with its new electronic clinical outcome assessment platform, Willis.  

The Journal of Medical Internet Research (JMIR) describes digital phenotyping as “near real-time data collection from personal digital devices, particularly smartphones, to better quantify the human phenotype.” 

According to the company, Willis consists of three parts:

  • OpenWillis is a shared library of methods in digital phenotyping.

  • WillisPipeline is intended for organizations collecting behavioral data and can commit computational resources to processing it for clinically meaningful measures.

  • WillisAPI permits digital health platforms to process the data they collect for measures that can help them better serve their users and customers. 

The company asserts that with WillisAPI, instead of investing in developing and validating novel measures, platforms can lean on existing measures with collective acceptance in the scientific community. 

Brooklyn Health will use the funds to increase its team, boost Willis’ proficiencies and hasten commercial deployments with pharmaceutical companies. 

“Measuring treatment efficacy in neuroscience clinical trials is hard because of how subjective clinical assessments can be,” Anzar Abbas, neuroscientist, founder and CEO of Brooklyn Health, told MobiHealthNews.

“Willis allows pharmaceutical sponsors to improve the accuracy and reliability of measures in their trials in a way they’ve never been able to before. It’s thrilling, because if we reduce barriers to drug development, we get closer to a future where patients get more targeted, precise and effective care.”

MARKET SNAPSHOT

Other companies in the CNS clinical trials space include Grey Matter Neurosciences, which secured $14 million in seed financing in January. 

The funds were used to develop an ultrasound headset for individuals with Alzheimer’s disease and test that device in clinical trials.

The financing was led by the Wittington Innovation Fund, with participation from the Toronto Innovation Acceleration Partners, the Ontario Brain Institute and Ontario’s Life Sciences Innovation Fund. 

The company also licensed advanced focused ultrasound technology developed at Sunnybrook Health Sciences Centre Research Institute. 

Lexeo Therapeutics utilizes gene therapy to address central nervous system diseases affecting both rare and prevalent patient populations. The company’s pipeline includes CNS-focused gene therapies, featuring a portfolio of approaches to treat the genetic underpinnings of Alzheimer’s disease.

Neumora is focused on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. 

IQVIA provides advanced analytics, technology and clinical research services for various disciplines in healthcare, including neurology, neurodegenerative diseases, psychiatry, sleep, CNS rare diseases and pain. 

TFS HealthScience is a mid-size contract research organization (CRO) that partners with biotech and pharmaceutical companies throughout their clinical development. 

TFS Neuroscience CRO has expertise across a range of neuroscience indications in neurology and the CNS, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), as well as in non-neurology areas such as psychiatry and pain, including addiction, schizophrenia and neuropathy.

Credit: Source link

READ ALSO

New AI can improve non-derma’s ability to diagnose skin conditions

Google Cloud outage disrupts AI services used in healthcare

ShareTweetSendSharePin
Previous Post

Snowflake named as data partner for LA28 Olympics

Next Post

Pacers fan allegedly stabbed Knicks supporter at Indiana brewery during playoff game

Related Posts

New AI can improve non-derma’s ability to diagnose skin conditions
Health

New AI can improve non-derma’s ability to diagnose skin conditions

June 13, 2025
Google Cloud outage disrupts AI services used in healthcare
Health

Google Cloud outage disrupts AI services used in healthcare

June 13, 2025
LucyRx, Personify Health partner for GLP-1 management
Health

LucyRx, Personify Health partner for GLP-1 management

June 12, 2025
Emerging technologies in healthcare, part 4: MedTech Innovator
Health

Emerging technologies in healthcare, part 4: MedTech Innovator

June 12, 2025
Cybersecurity provider Nexus IT, Diatonic Healthcare announce M funding
Health

Cybersecurity provider Nexus IT, Diatonic Healthcare announce $60M funding

June 11, 2025
Capital Rx acquires Amino Health
Health

Capital Rx acquires Amino Health

June 11, 2025
Next Post
Pacers fan allegedly stabbed Knicks supporter at Indiana brewery during playoff game

Pacers fan allegedly stabbed Knicks supporter at Indiana brewery during playoff game

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

What's New Here!

How Rory McIlroy landed a favorable pairing as 2025 US Open tee times revealed

How Rory McIlroy landed a favorable pairing as 2025 US Open tee times revealed

June 10, 2025
Yankees’ Jazz Chisholm Jr. exits early with neck tightness

Yankees’ Jazz Chisholm Jr. exits early with neck tightness

June 11, 2025
Women’s sports are thriving in Saudia Arabia

Women’s sports are thriving in Saudia Arabia

June 7, 2025
Trump tariff delay trade is back, sending U.S. markets up on EU reprieve—but it ‘doesn’t pay like it used to’

Trump tariff delay trade is back, sending U.S. markets up on EU reprieve—but it ‘doesn’t pay like it used to’

May 27, 2025
Google Photos gets new AI features for its 10-year anniversary

Google Photos gets new AI features for its 10-year anniversary

May 28, 2025
Nintendo Switch 2 has officially launched, here’s everything you need to know

Nintendo Switch 2 has officially launched, here’s everything you need to know

June 5, 2025
MLB best bets, picks Thursday

MLB best bets, picks Thursday

May 15, 2025

About

World Tribune is an online news portal that shares the latest news on world, business, health, tech, sports, and related topics.

Follow us

Recent Posts

  • India moves to tap its rare earth reserves. Can it ease reliance on China?
  • New York-area golfers surprisingly in US Open contention after Day 1
  • Reddit adds analytics and drafts for comments
  • Scale AI founder Wang announces exit for Meta part of $14 billion deal

Newslatter

Loading
  • Submit Your Content
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2024 World Tribune - All Rights Reserved!

No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food

© 2024 World Tribune - All Rights Reserved!

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In